期刊文献+

Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer 被引量:9

Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer
下载PDF
导出
摘要 AIM: To evaluate the expression of special AT-rich sequence-binding protein 1 (SATB1 ) gene in colorectal cancer and its role in colorectal cancer cell proliferation and invasion.METHODS: Immunohistochemistry was used to detect the protein expression of SATB1 in 30 colorectal cancer (CRC) tissue samples and pair-matched adjacent nontumor samples. Cell growth was investigated after enhancing expression of SATB1. Wound-healing assay and Transwell assay were used to investigate the impact of SATB1 on migratory and invasive abilities of SW480 cells in vitro . Nude mice that received subcutaneous implantation or lateral tail vein were used to study the effects of SATB1 on tumor growth or metastasis in vivo . RESULTS: SATB1 was over-expressed in CRC tissues and CRC cell lines. SATB1 promotes cell proliferation and cell cycle progression in CRC SW480 cells. SATB1 over-expression could promote cell growth in vivo . In addition, SATB1 could significantly raise the ability of cell migration and invasion in vitro and promote the ability of tumor metastasis in vivo . SATB1 could up-regulate matrix metalloproteases 2, 9, cyclin D1 and vimentin, meanwhile SATB1 could down-regulate E-cadherin in CRC. CONCLUSION: SATB1 acts as a potential growth and metastasis promoter in CRC. SATB1 may be useful as a therapeutic target for CRC. AIM: To evaluate the expression of special AT-rich sequence-binding protein 1 (SATB1) gene in colorectal cancer and its role in colorectal cancer cell proliferation and invasion. METHODS: Immunohistochemistry was used to detect the protein expression of SATB1 in 30 colorectal cancer (CRC) tissue samples and pair-matched adjacent non-tumor samples. Cell growth was investigated after enhancing expression of SATB1. Wound-healing assay and Transwell assay were used to investigate the impact of SATB1 on migratory and invasive abilities of SW480 cells in vitro. Nude mice that received subcutaneous implantation or lateral tail vein were used to study the effects of SATB1 on tumor growth or metastasis in vivo. RESULTS: SATB1 was over-expressed in CRC tissues and CRC cell lines. SATB1 promotes cell proliferation and cell cycle progression in CRC SW480 cells. SATB1 overexpression could promote cell growth in vivo. In addition, SATB1 could significantly raise the ability of cell migration and invasion in vitro and promote the ability of tumor metastasis in vivo. SATB1 could up-regulate matrix metalloproteases 2, 9, cyclin D1 and vimentin, meanwhile SATB1 could down-regulate E-cadherin in CRC. CONCLUSION: SATB1 acts as a potential growth and metastasis promoter in CRC. SATB1 may be useful as a therapeutic target for CRC.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第15期2331-2339,共9页 世界胃肠病学杂志(英文版)
基金 Supported by The National Natural Science Foundation of China, No. 81101580
关键词 SPECIAL AT-rich sequence-binding protein 1 COLORECTAL cancer Proliferation Migration INVASION Special AT-rich sequence-binding protein 1 Colorectal cancer Proliferation Migration Invasion
  • 相关文献

参考文献6

二级参考文献64

  • 1Jing Gao, Yan-Yan Li, Ping-Nai Sun, Lin Shen.Comparative analysis of dideoxy sequencing,the KRAS StripAssay and pyrosequencing for detection of KRAS mutation[J].World Journal of Gastroenterology,2010,16(38):4858-4864. 被引量:8
  • 2干月波,蔡心涵,郑树.结直肠癌旁粘膜ras基因突变的研究[J].肿瘤防治研究,1994,21(6):350-351. 被引量:5
  • 3Folkesson J,Birgisson H,Pahlman L,Cedermark B,Glimelius B,Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005; 23: 5644-5650.
  • 4Adell G,Sun XF,Stal O,Klintenberg C,Sj dahl R,Nordenskj ld B. p53 status: an indicator for the effect of preoperative radiotherapy of rectal cancer. Radiother Oncol 1999; 51: 169-174.
  • 5Bujko K,Nowacki MP,Nasierowska-Guttmejer A,Michalski W,Bebenek M,Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006; 93: 1215-1223.
  • 6de Bruin EC,van de Velde CJ,van de Pas S,Nagtegaal ID, van Krieken JH,Gosens MJ,Peltenburg LT,Medema JP, Marijnen CA. Prognostic value of apoptosis in rectal cancer patients of the dutch total mesorectal excision trial: radiotherapy is redundant in intrinsically high-apoptotic tumors. Clin Cancer Res 2006; 12: 6432-6436.
  • 7Adell GC,Zhang H,Evertsson S,Sun XF,St l OH,Nordenskj ld BA. Apoptosis in rectal carcinoma: prognosis and recurrence after preoperative radiotherapy. Cancer 2001; 91: 1870-1875.
  • 8Schwandner O,Schiedeck TH,Bruch HP,Duchrow M,Windhoevel U,Broll R. Apoptosis in rectal cancer: prognostic significance in comparison with clinical histopathologic,and immunohistochemical variables. Dis Colon Rectum 2000; 43: 1227-1236.
  • 9Jonges LE,Nagelkerke JF,Ensink NG,van der Velde EA, Tollenaar RA,Fleuren GJ,van de Velde CJ,Morreau H,Kuppen PJ. Caspase-3 activity as a prognostic factor in colorectal carcinoma. Lab Invest 2001; 81: 681-688.
  • 10Huang Y,Duan H,Sun Y. Elevated expression of SAG/ ROC2/Rbx2/Hrt2 in human colon carcinomas: SAG does not induce neoplastic transformation,but antisense SAG transfection inhibits tumor cell growth. Mol Carcinog 2001; 30: 62-70.

共引文献37

同被引文献35

引证文献9

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部